• 2021

  • Share sale

  • IPO NASDAQ

  • IPO NASDAQ

  • 2020

  • Share sale

  • IPO NASDAQ

  • Acquired by Bayer
    $875M + milestones

  • 2019

  • Milestone

  • Share sale

  • 2018

  • IPO NASDAQ

  • IPO NASDAQ

  • 2017

  • Share sale

  • 2016

  • Acquired by Juno Aspire Pharma
    Undisclosed

  • Share sale

  • 2015

  • IPO EURONEXT

  • IPO EURONEXT

  • Acquired by Edwards
    Lifesciences Corporation USD $400M

  • Share sale

  • 2014

  • Acquired by Agenus Undisclosed

  • Acquired by Bayer
    USD $2.9B

  • IPO NASDAQ

  • IPO NASDAQ

  • 2013

  • Acquired by British American Tobacco
    Undisclosed

  • IPO
    NASDAQ

  • Acquired by Salix Pharmaceuticals Inc.
    USD $2.6B

  • 2012

  • NASDAQ. Acquired by Amgen
    USD$1.1b

  • Acquired by Celgene
    USD$350m + USD$575m milestones

  • Acquired by Jazz
    Pharmaceuticals
    USD$700m

  • 2011

  • Acquired by Cornerstone Undisclosed

  • 2010

  • Acquired by J&J Undisclosed

  • 2009

  • Merged with Microscience

  • 2008

  • Acquired by Wyeth Pharmaceuticals
    USD$150m

  • 2007

  • IPO
    Oslo Børs

  • 2006

  • NASDAQ

  • Acquired by Pfizer Undisclosed

Advent Life Sciences. Innovation. Clarity. Execution.